Smart radiation for prostate cancer: daily adjustments may cut urinary side effects

NCT ID NCT07276438

First seen Jan 09, 2026 · Last updated May 15, 2026 · Updated 21 times

Summary

This study compares two ways of giving stereotactic body radiation therapy (SBRT) for prostate cancer that hasn't spread. In standard SBRT, the radiation plan is fixed. In the new approach, doctors use daily MRI or CT scans to adjust the plan to match the patient's anatomy that day, aiming to spare healthy tissue. The goal is to see if this adaptive method lowers short-term urinary side effects. About 186 men with early-stage prostate cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE I PROSTATE CANCER AJCC V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UCLA / Jonsson Comprehensive Cancer Center

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.